RegenXBio(DE:RB0)
€6.90-0.19 (-2.68%)
DE:RB0
RegenXBio earnings date
€6.90
At close:-0.19 (-2.68%)
RegenXBio (RB0) Q2 2021 Earnings Report
1 Followers
DE:RB0 Q2 2021 EPS Results
- Actual EPS
- -EUR 1.22
- Consensus EPS
- -EUR 1.00
- Beat/Miss
- Missed by -EUR 0.22
- One Year Ago EPS
- -EUR 0.81
DE:RB0 Q2 2021 Revenue Results
- Actual Revenue
- EUR 19.73M
- Expected Revenue
- EUR 18.96M
- Beat/Miss
- Beat by +EUR 772.69K
- YoY Revenue Growth
- +33.01%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/09/2021
- Time
- After Close
- Conference Call
- Monday, August 9, 2021
DE:RB0 Upcoming Earnings
RegenXBio's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:RB0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -0.86- | -1.16 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -1.15-0.56 | -1.07 | 48.33% (+0.52) | |
| Aug 06, 2026 | 2026 (Q2) | 0.070.39 | -1.24 | 131.16% (+1.62) | |
| May 14, 2026 | 2026 (Q1) | -1.20-1.54 | 0.11 | -1533.33% (-1.65) | |
| Mar 05, 2026 | 2025 (Q4) | -0.86-1.16 | -0.9 | -28.71% (-0.26) | |
| Nov 06, 2025 | 2025 (Q3) | -1.15-1.07 | -1.05 | -2.56% (-0.03) | |
| Aug 07, 2025 | 2025 (Q2) | -0.84-1.24 | -0.94 | -31.43% (-0.30) | |
| May 12, 2025 | 2025 (Q1) | 0.410.11 | -1.24 | 108.70% (+1.34) | |
| Mar 13, 2025 | 2024 (Q4) | -1.02-0.90 | -1.28 | 29.37% (+0.38) | |
| Nov 06, 2024 | 2024 (Q3) | -1.00-1.05 | -1.26 | 17.02% (+0.21) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
